Injectable formulation of disodium 1-[2-(carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate (PROLI/NO), an ultrafast nitric oxide donor prodrug
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 95 (1) , 108-115
- https://doi.org/10.1002/jps.20486
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Selective Pulmonary Vasodilation by Intravenous Infusion of an Ultrashort Half-life Nucleophile/Nitric Oxide AdductAnesthesiology, 1998
- Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhageJournal of Neurosurgery, 1997
- Boundary Layer Infusion of Nitric Oxide Reduces Early Smooth Muscle Cell Proliferation in the Endarterectomized Canine ArteryJournal of Surgical Research, 1997
- Localizing Antithrombotic and Vasodilatory Activity with a Novel, Ultrafast Nitric Oxide DonorJournal of Medicinal Chemistry, 1996
- Toxicity of D-prolinePublished by Springer Nature ,1990
- A study of tobacco carcinogenesis XLII. Bioassay in mice of some structural analogues of tobacco-specific nitro saminesCancer Letters, 1988
- Toxicity of L-proline toward rat hippocampal neuronsBrain Research, 1988
- D-proline: Stereospecificity and sodium chloride dependence of lethal convulsant activity in the chickPharmacology Biochemistry and Behavior, 1978
- Null carcinogenic effect of large doses of nitrosoproline and nitrosohydroxyproline in wistar ratsFood and Cosmetics Toxicology, 1976
- New method for nitrosation of proline and related sec-.alpha.-amino acids to N-nitrosamino acids with possible oncogenic activityJournal of Medicinal Chemistry, 1973